CANINE VACCINE

Brand Owner (click to sort) Address Description
COMMANDER BIOCOR ANIMAL HEALTH INC. 2720 North 84th Street Omaha NE 68134 canine vaccine;
COUGHGUARD SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 CANINE VACCINE;COUGH GUARD;
EPIVAXINE SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 556 Morris Avenue Summit NJ 07901 Canine Vaccine;
FIRSTDOSE SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia PA 19102 CANINE VACCINE;FIRST DOSE;
GALAXY SOLVAY VETERINARY, INC. P.O. BOX 7348 PRINCETON NJ 08543 Canine Vaccine;
GALAXY INTERVET INC. 2 Giralda Farms Madison NJ 07940 Canine vaccine;
KENNEL-JEC-2 Boehringer Ingelheim Animal Health USA Inc. 3239 Satellite Boulevard Duluth GA 30096 Canine Vaccine;
NOVAMUNE BURROUGHS WELLCOME CO. Research Triangle Park NC Canine Vaccine;NOVIMMUNE;
PARVOGEN Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 Canine Vaccine;
THE PUPPYSHOT ELANCO US INC. 2500 INNOVATION WAY GREENFIELD IN 46140 CANINE VACCINE;PUPPY SHOT;
VANGUARD NORDEN LABORATORIES, INC. Lincoln NE CANINE VACCINE;
VANGUARD ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 CANINE VACCINE;
VANGUARD PLUS ZOETIS SERVICES 10 Sylvan Way Parsippany NJ 07054 canine vaccine;
VAX PAC AMERICAN HOME PRODUCTS CORPORATION New York NY CANINE VACCINE;VACCINATION PACK;VACCINATION KITS COMPRISING VACCINE, SYRINGE AND NEEDLE AND ALCOHOL PAD;PAC;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.